Mendas Pharma Profile
Key Indicators
- Authorised Capital ₹ 10.00 Cr
as on 19-12-2024
- Paid Up Capital ₹ 10.00 Cr
as on 19-12-2024
- Company Age 5 Year, 10 Days
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 78.00 Cr
as on 19-12-2024
- Revenue %
(FY 2022)
- Ebitda
- Net Worth 95303.81%
(FY 2022)
- Total Assets 330.66%
(FY 2022)
About Mendas Pharma
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 10.00 Cr and a paid-up capital of Rs 10.00 Cr.
The company currently has active open charges totaling ₹78.00 Cr.
Umesh Mendapara, Alpeshkumar Mendapara, Shailesh Mendpara, and Five other members serve as directors at the Company.
- CIN/LLPIN
U24100MH2019PTC334311
- Company No.
334311
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
11 Dec 2019
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Mendas Pharma?
Board Members(8)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Umesh Mendapara  | Director | 11-Dec-2019 | Current |
| Alpeshkumar Mendapara | Director | 11-Dec-2019 | Current |
| Shailesh Mendpara | Director | 11-Dec-2019 | Current |
| Parth Mendpara | Director | 11-Dec-2019 | Current |
| Sanjay Mendpara | Director | 11-Dec-2019 | Current |
| Bhaveshkumar Mendapara | Director | 11-Dec-2019 | Current |
Financial Performance of Mendas Pharma.
Mendas Pharma Private Limited, for the financial year ended 2022, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth Soared by an impressive increase of 95303.81%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss | |||||||
| Net Worth |
| ||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Mendas Pharma?
In 2022, Mendas Pharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Apex Healthcare LimitedActive 17 years 11 monthsUmesh Mendapara, Alpeshkumar Mendapara and 2 more are mutual person
- Mendas Corporation Private LimitedActive 7 years 8 months
Umesh Mendapara, Alpeshkumar Mendapara and 5 more are mutual person
- Mendas Diamonds Private LimitedActive 5 years 10 days
Umesh Mendapara, Alpeshkumar Mendapara and 5 more are mutual person
- Plasma Energy Applied Technologies Ankleshwar Private LimitedActive 16 years 2 months
Umesh Mendapara is a mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 10 May 2021 | ₹39.00 Cr | Open |
Others Creation Date: 10 May 2021 | ₹39.00 Cr | Open |
How Many Employees Work at Mendas Pharma?
Unlock and access historical data on people associated with Mendas Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Mendas Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Mendas Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
